Kvartsberg, Hlin http://orcid.org/0000-0002-4481-508X
Lashley, Tammaryn
Murray, Christina E.
Brinkmalm, Gunnar
Cullen, Nicholas C.
Höglund, Kina
Zetterberg, Henrik
Blennow, Kaj
Portelius, Erik
Funding for this research was provided by:
H2020 European Research Council
Vetenskapsrådet
Torsten Söderbergs Stiftelse
Hjärnfonden
Knut och Alice Wallenbergs Stiftelse
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
Stiftelsen för Gamla Tjänarinnor
Alzheimerfonden
Foundation for Research on Alzheimer
Swedish state support for Clinical Research
Alzheimer's Research UK
Leonard Wolfson Centre for Experimental Neurology
UK dementia Research Institute at UCL
Reta Lila Weston Institute for Neurological Studies
Medical Research Counsil
Article History
Received: 6 August 2018
Revised: 14 September 2018
Accepted: 14 September 2018
First Online: 22 September 2018
Compliance with ethical standards
:
: HZ is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg, has served at advisory boards of Eli Lilly, Roche Diagnostics and Wave and has received travel support from TEVA. KB has served as a consultant or at advisory boards for Alzheon, BioArctic, Biogen, Eli Lilly, Fujirebio Europe, IBL International, Merck, Pfizer, and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. KH has served as consultant for Eisai and Abbvie.